Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.3B 1.11B 1.04B 954M 1.79B 125B 1.82B 12.32B 4.8B 62.53B 4.89B 4.78B 207B P/E 2026 *
26.2x
P/E 2027 * 13.4x
Enterprise Value 2.79B 2.39B 2.24B 2.05B 3.84B 267B 3.89B 26.41B 10.29B 134B 10.48B 10.25B 444B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.5x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day+0.90%
1 week-8.72%
Current month+0.54%
1 month-11.94%
3 months+10.71%
6 months+37.10%
Current year+34.78%
1 week 16.44
Extreme 16.44
18.37
1 month 16.04
Extreme 16.04
20.49
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.42
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 2026-04-30
Director of Finance/CFO 54 2023-06-27
Chief Tech/Sci/R&D Officer - 2026-02-16
Director TitleAgeSince
Chairman 64 2012-01-02
Director/Board Member 81 1991-12-31
Director/Board Member 65 2005-12-31
Date Insider Type Main position Quantity % Market Cap.
7/3/26 Tax

Chief Financial Officer

-5,226 0.0067%
7/1/26 Free

Executive/Senior Manager

5,590 0.0072%
7/1/26 Free

Executive/Senior Manager

11,180 0.0144%
Change 5-day change 1-year change 3-year change Capi.($)
+0.90%-8.72%+22.37%-60.24% 1.3B
+2.19%+4.84%-12.03%+10.93% 202B
+1.14%+2.28%+0.69%+11.50% 119B
+1.06%+1.34%+8.69%+78.71% 60.69B
-1.37%-6.57%+28.86%+58.31% 52.38B
+2.33%+4.69%-3.84%-30.36% 52.3B
+2.35%+2.89%+14.54%-11.79% 34.85B
+5.16%-4.14% - - 30.06B
-0.20%+1.05%+42.46%-10.20% 24.85B
-0.29%-3.87%-6.22%+24.74% 23.84B
Average +1.33%-0.45%+10.61%+7.96% 60.16B
Weighted average by Cap. +1.53%+2.27%+1.64%+16.92%

Financials

2026 *2027 *
Net sales 1.67B 1.43B 1.34B 1.23B 2.3B 160B 2.34B 15.84B 6.18B 80.42B 6.29B 6.15B 266B 1.73B 1.48B 1.38B 1.27B 2.38B 165B 2.41B 16.35B 6.37B 83B 6.49B 6.35B 275B
Net income 42.03M 35.99M 33.66M 30.82M 57.85M 4.02B 58.63M 398M 155M 2.02B 158M 154M 6.68B 78.69M 67.39M 63.02M 57.69M 108M 7.53B 110M 745M 290M 3.78B 295M 289M 12.51B
Net Debt 1.49B 1.28B 1.19B 1.09B 2.05B 143B 2.08B 14.09B 5.49B 71.53B 5.59B 5.47B 237B 1.28B 1.1B 1.03B 942M 1.77B 123B 1.79B 12.16B 4.74B 61.71B 4.82B 4.72B 204B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
26-08-21 US$16.74 +0.90% 551,799
26-08-20 US$16.59 -3.77% 582,346
26-08-19 US$17.24 -1.77% 652,366
26-08-18 US$17.55 -0.62% 541,279
26-08-17 US$17.66 -3.71% 541,153
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
16.74USD
Average target price
19.56USD
Spread / Average Target
+16.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock